Immunomodulation with regulatory T cells and Fasligand ameliorate established inflammatory colitis

Gut

Volumn 62, Issue 8, 2013, Pages 1228-1230

  Kaminitz, Ayelet ^a   Askenasy, Nadir ^a   Yolcu, Esma S ^b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; APOPTOSIS; CD4+ CD25+ T LYMPHOCYTE; CELL DEATH; CELL FRACTIONATION; COLITIS; CONTROLLED STUDY; EFFECTOR CELL; GENE OVEREXPRESSION; IMMUNOMODULATION; IMMUNOPHENOTYPING; INFLAMMATION; LETTER; LYMPHOCYTE FUNCTION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL;

INFLAMMATORY BOWEL DISEASE;

ADOPTIVE TRANSFER; ANIMALS; CHRONIC DISEASE; COLITIS; FAS LIGAND PROTEIN; IMMUNOMODULATION; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, REGULATORY;

EID: 84880300759     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-304432     Document Type: Letter

References (10)

1. Peppelenbosch MP, van Deventer SJ. T cell apoptosis and inflammatory bowel disease. Gut 2004;53:1556-8.
2. Mudter J, Neurath MF. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 2007;56:293-303.
3. Veltkamp C, Anstaett M, Wahl K, et al. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment. Gut 2011;60:1345-53.
4. Weitkamp JH, Koyama T, Rock MT, et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut 2013;62:73-82.
5. Atreya R, Mudter J, Finotto S, et al. Blockade of IL-6 transsignaling suppresses T cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn's disease and experimental colitis in vivo. Nat Med 2000;6:583-8.
6. Yarkoni S, Sagiv Y, Kaminitz A, et al. Interleukin 2 targeted therapy in inflammatory bowel disease. Gut 2009;58:1705-6.
7. Kaminitz A, Yolcu ES, Stein J, et al. Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice. J Autoimmun 2011;37:39-47.
8. Kaminitz A, Yolcu ES, Askenasy EM, et al. Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice. PLoS One 2011;6:e21630.
9. Yolcu ES, Ash S, Kaminitz A, et al. Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunol Cell Biol 2008;86:650-8.
10. Weiss EM, Schmidt A, Vobis D, et al. Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells. J Immunol 2011;187:1684-91.